To the Editor: Submucosal nasopharyngeal carcinoma (NPC) is very uncommon, comprising only 8.8% of all tumors in the nasopharynx.[1] However, given difficulties
Background: Secondary preventive therapies play a key role in the prevention of adverse outcomes after coronary artery bypass grafting (CABG). However, medicati